article thumbnail

How medical device sales teams can embrace digital transformation

pharmaphorum

Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than for medical device sales teams, who typically schedule regular visits to hospitals and doctors’ offices to create a personal, ongoing connection that drives forward the sales process.

Sales 98
article thumbnail

EU regulator lifts GSK amid torrid week for company’s pipeline

pharmaphorum

The EU regulator has formally started an accelerated assessment of GSK’s RSV vaccine RSVPreF3 OA for older adults, with a decision now expected in the third quarter of next year – a timeline that could allow GSK to beat rival RSV shot developers, including Pfizer, to the European market. It hasn’t yet been filed with the FDA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leading direct-to-consumer marketing companies for pharmaceuticals

Pharmaceutical Technology

Pharmaceutical companies have also entered the social media marketing domain in compliance with governmental regulations to communicate directly with patients using covert persuasion methods such as collaboration with social media influencers. Discover the leading direct-to-consumer pharmaceutical marketing companies.

Marketing 130
article thumbnail

STAT+: Pharmalittle: A ‘King Kong’ of weight-loss drugs is looming; FTC orders Illumina to divest Grail

STAT News

health regulators to be prescribed for losing weight and keeping it off, Mounjaro could be one of the highest-selling drugs of all time with annual sales exceeding $25 billion. One diabetes doctor called it a “King Kong” of diet drugs. In the coming months, it is widely expected to get the go-ahead from U.S.

Drugs 98
article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

According to the figures compiled in the third quarter of last year, pharma brands were projected to spend around $10 billion in 2020 on digital advertising aimed at all groups including doctors, a compound annual growth rate of more than 13% since 2014. Hale added: “Delivery across omnichannels is going to be key.

article thumbnail

FDA backs pharmacist prescribing of Paxlovid for COVID

pharmaphorum

The regulator has revised the emergency use authorisation (EUA) for Paxlovid (nirmatrelvir and ritonavir) to allow state-licensed pharmacists to prescribe the drug to patients, providing they can provide recent health records and a list of current medicines they are taking. — President Biden (@POTUS) July 7, 2022. It made $1.5

Pharmacy 113
article thumbnail

FDA holds back from action over Xeljanz safety study

pharmaphorum

The US regulator slapped a black box warning on the 10mg dose, although that doesn’t appear to have applied much of a brake on sales in it approved indications of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and juvenile idiopathic arthritis. First approved in 2o12, Xeljanz brought in sales of more than $1.7

Sales 61